Influenza Clinical Trials in St Louis, Missouri
4 recruitingSt Louis, Missouri
Showing 1–4 of 4 trials
Recruiting
Phase 3
A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza
Influenza
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)7,500 enrolled181 locationsNCT07159763
Recruiting
Phase 3
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
COVID-19Lower Respiratory Tract InfectionImmunocompromised+1 more
Ansun Biopharma, Inc.274 enrolled67 locationsNCT03808922
Recruiting
Dissecting Human Immune Responses to Infection With Influenza or SARS-CoV-2
InfluenzaSARS-CoV-2 (COVID-19) InfectionImmune Response of Host
Washington University School of Medicine300 enrolled1 locationNCT06848309
Recruiting
Phase 4
Characterizing the Human Airway Immune Response to FluMist Vaccination
Healthy Young AdultsInfluenza VaccinesInfluenza Vaccine Response
Washington University School of Medicine30 enrolled1 locationNCT07177417